Published in Ann Oncol on January 01, 2002
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood (2009) 2.43
Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study. J Clin Oncol (2011) 2.40
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat Genet (2014) 2.34
Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control. Leuk Lymphoma (2011) 1.54
Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol (2012) 1.53
Conserved Molecular Underpinnings and Characterization of a Role for Caveolin-1 in the Tumor Microenvironment of Mature T-Cell Lymphomas. PLoS One (2015) 1.40
A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome. Ann Oncol (2011) 1.35
Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses. J Hematol Oncol (2014) 1.34
Nasal NK/T-cell lymphoma: epidemiology and pathogenesis. Int J Hematol (2008) 1.24
Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies. J Clin Pathol (2008) 1.16
Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma. J Hematol Oncol (2012) 1.16
Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature. Diagn Pathol (2012) 1.15
Refining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas. Leuk Lymphoma (2011) 1.09
A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma. ISRN Hematol (2011) 1.04
Peripheral T-cell Lymphoma with Cyclin D1 overexpression: a case report. Diagn Pathol (2012) 0.99
Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomas. Br J Haematol (2010) 0.97
Clinicopathologic characteristics of T-cell non-Hodgkin's lymphoma: a single institution experience. Korean J Intern Med (2009) 0.96
Impact of autologous and allogeneic stem cell transplantation in peripheral T-cell lymphomas. Adv Hematol (2010) 0.96
Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant. Leuk Lymphoma (2012) 0.95
Non-anaplastic peripheral t-cell lymphoma in childhood and adolescence: a Children's Oncology Group study. Pediatr Blood Cancer (2008) 0.91
Long-term complete remission with belinostat in a patient with chemotherapy refractory peripheral T-cell lymphoma. J Hematol Oncol (2013) 0.89
The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas. Blood Cancer J (2014) 0.88
Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma. Haematologica (2012) 0.88
Diagnosis of systemic metastatic retinal lymphoma. Acta Ophthalmol (2011) 0.87
Prognostic markers in peripheral T-cell lymphoma. Curr Hematol Malig Rep (2010) 0.86
No survival improvement for patients with angioimmunoblastic T-cell lymphoma over the past two decades: a population-based study of 1207 cases. PLoS One (2014) 0.85
Nodal peripheral T-cell lymphomas and, in particular, their lymphoepithelioid (Lennert's) variant are often derived from CD8(+) cytotoxic T-cells. Virchows Arch (2004) 0.85
How to predict the outcome in mature T and NK cell lymphoma by currently used prognostic models? Blood Cancer J (2012) 0.83
Peripheral T-cell lymphoma: review and updates of current management strategies. Adv Hematol (2010) 0.82
High-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factors. Biol Blood Marrow Transplant (2011) 0.82
Follicular helper T cells: implications in neoplastic hematopathology. Semin Diagn Pathol (2011) 0.81
Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States. J Clin Oncol (2016) 0.80
Romidepsin for the Treatment of Peripheral T-Cell Lymphoma. J Adv Pract Oncol (2015) 0.80
T-cell lymphomas in South america and europe. Rev Bras Hematol Hemoter (2012) 0.79
Angioimmunoblastic T-cell lymphoma mimicking Crohn's disease. Dig Dis Sci (2007) 0.79
Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network. Cancer (2014) 0.78
Primary oral non-Hodgkin's lymphoma - A clinicopathologic study with immunohistochemical analysis. J Int Soc Prev Community Dent (2014) 0.78
Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders. Exp Mol Med (2015) 0.77
An update on the management of peripheral T-cell lymphoma and emerging treatment options. J Blood Med (2011) 0.76
[Application of digital pathology tools. An unusual case of non-Hodgkin lymphoma]. Pathologe (2012) 0.76
An update in management of noncutaneous T-cell lymphomas. Adv Hematol (2010) 0.75
New developments in the treatment of peripheral T-cell lymphoma - role of Belinostat. Cancer Manag Res (2015) 0.75
Clinical and epidemiologic characteristics of non Hodgkin's lymphoma in Bedouins in the south of Israel. Springerplus (2013) 0.75
Pharmacodynamic and pharmacokinetic study of pegylated liposomal doxorubicin combination (CCOP) chemotherapy in patients with peripheral T-cell lymphomas. Acta Pharmacol Sin (2011) 0.75
Anti-thymocyte globulin could improve the outcome of allogeneic hematopoietic stem cell transplantation in patients with highly aggressive T-cell tumors. Blood Cancer J (2015) 0.75
Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma. Ther Clin Risk Manag (2011) 0.75
Romidepsin for the Treatment of Peripheral T-Cell Lymphoma. Oncologist (2015) 0.75
Relapsed angioimmunoblastic T-cell lymphoma with acquired expression of CD20: a case report and review of the literature. BMC Clin Pathol (2013) 0.75
Cerebellar EBV-associated diffuse large B cell lymphoma following angioimmunoblastic T cell lymphoma. J Hematop (2015) 0.75
Peripheral T-cell lymphoma presenting as an ischemic stroke in a 23-year-old woman: a case report and review of the literature. J Med Case Rep (2009) 0.75
Comparison of Total Body Irradiation (TBI) Conditioning with Non-TBI for Autologous Stem Cell Transplantation in Newly Diagnosed or Relapsed Mature T- and NK-Cell Non-Hodgkin Lymphoma. Cancer Res Treat (2016) 0.75
Novel therapies for peripheral T-cell lymphomas. Ther Adv Hematol (2013) 0.75
T-cell lymphoma with POEMS syndrome. Oncol Lett (2014) 0.75
Should eligible patients with T-cell lymphoma receive high-dose therapy and autologous stem cell transplant in the upfront setting? Curr Oncol Rep (2010) 0.75
[Peripheral NK/T-cell lymphoma]. Pathologe (2007) 0.75
Toward a Biology-Driven Treatment Strategy for Peripheral T-cell Lymphoma. Clin Med Insights Blood Disord (2017) 0.75
Clinical characteristics of angioimmunoblastic T-cell lymphoma in China and C-reactive protein as an independent prognostic factor. Medicine (Baltimore) (2017) 0.75
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol (1999) 17.43
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol (1999) 12.42
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
Fabrication of microfluidic systems in poly(dimethylsiloxane). Electrophoresis (2000) 9.45
Analysis of survival by tumor response. J Clin Oncol (1983) 5.91
Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol (2001) 5.46
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med (1992) 5.42
New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol (1998) 4.92
The will and the ways: development and validation of an individual-differences measure of hope. J Pers Soc Psychol (1991) 4.55
Recombinant outer surface protein a from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice. J Infect Dis (1991) 3.58
2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol (2000) 3.38
Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans. J Virol (1986) 3.36
Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med (1995) 3.31
Laparoscopic versus minilaparotomy cholecystectomy: a randomised trial. Lancet (1994) 3.29
Updated Kiel classification for lymphomas. Lancet (1988) 3.25
Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol (1998) 3.21
Quality assurance in immunohistochemistry: results of an interlaboratory trial involving 172 pathologists. Am J Surg Pathol (2002) 3.05
Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood (1999) 2.95
Late mortality after surgery for peptic ulcer. N Engl J Med (1982) 2.73
Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms. Ann Oncol (2000) 2.66
Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology (2000) 2.65
Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol (1998) 2.64
Familial multiple myeloma: a family study and review of the literature. J Natl Cancer Inst (2001) 2.62
Examination of cardiorespiratory changes during upper gastrointestinal endoscopy. Comparison of monitoring of arterial oxygen saturation, arterial pressure and the electrocardiogram. Anaesthesia (1991) 2.52
The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology (2000) 2.51
The western black-legged tick, Ixodes pacificus: a vector of Borrelia burgdorferi. Am J Trop Med Hyg (1985) 2.50
Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med (1997) 2.45
Occurrence of antibody to salivary duct epithelium in Sjogren's disease, rheumatoid arthritis, and other arthritides. A clinical and laboratory study. Ann Rheum Dis (1967) 2.43
A case-control study of non-Hodgkin's lymphoma and the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) in eastern Nebraska. Epidemiology (1990) 2.40
The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb Symp Quant Biol (1999) 2.40
The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study. Scand J Immunol (1985) 2.40
Increasing physician productivity and the hospitalization characteristics of practices using Medex. A progress report. Northwest Med (1971) 2.34
The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997. Hematol J (2000) 2.34
Mantle cell lymphoma-- an entity comes of age. Blood (1996) 2.30
The role of prefrontal cortex and posterior parietal cortex in task switching. Proc Natl Acad Sci U S A (2000) 2.28
MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology (1997) 2.25
Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood (2000) 2.23
Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev (1984) 2.22
The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols. Sarcoma (2001) 2.10
Dietary factors and non-Hodgkin's lymphoma in Nebraska (United States). Cancer Causes Control (1994) 2.07
Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol (2001) 2.06
Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy. Nat Genet (1999) 2.04
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia (2007) 2.03
T-cell-rich B-cell lymphoma. A clinicopathologic study of eight cases. Am J Clin Pathol (1995) 2.02
Clinical features and prognosis of follicular large-cell lymphoma: a report from the Nebraska Lymphoma Study Group. J Clin Oncol (1993) 2.00
High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N Engl J Med (1987) 1.98
Toward normative expert systems: Part I. The Pathfinder project. Methods Inf Med (1992) 1.97
Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet (1999) 1.96
Generation and characterization of a delta F508 cystic fibrosis mouse model. Nat Genet (1995) 1.96
Myeloid sarcoma: clinical and morphologic criteria useful for diagnosis. Int J Surg Pathol (2003) 1.95
Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs. J Clin Oncol (1991) 1.94
Arterial oxygen saturation during upper gastrointestinal endoscopy: the effects of a midazolam/pethidine combination. Gut (1990) 1.93
Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens. J Immunol (1985) 1.91
Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford) (2006) 1.84
Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens. EMBO J (1998) 1.83
Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2). N Engl J Med (1983) 1.82
Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood (1993) 1.82
Is sclerosing angiomatoid nodular transformation (SANT) of the splenic red pulp identical to inflammatory pseudotumour? Report of 16 cases. Histopathology (2008) 1.82
Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. Lancet (2003) 1.80
Production of a severe cystic fibrosis mutation in mice by gene targeting. Nat Genet (1993) 1.80
Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum Pathol (1985) 1.79
Central venous catheterisation. Ann R Coll Surg Engl (1980) 1.78
Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer. Br J Surg (1996) 1.78
Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate. Eur J Cancer (2002) 1.77
International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury. J Clin Oncol (1999) 1.76
Malignant lymphoma, lymphoblastic. Cancer (1976) 1.75
Exponential survival trees. Stat Med (1989) 1.75
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol (1997) 1.75
Gastric studies in sjögren's syndrome. Gut (1966) 1.73
DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status. Leukemia (2008) 1.70
Integrative assessment of multiple pesticides as risk factors for non-Hodgkin's lymphoma among men. Occup Environ Med (2003) 1.70
Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol (1999) 1.70
Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial. J Clin Oncol (1993) 1.69
The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol (2000) 1.68
Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res (1993) 1.68
Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group. Cancer (1997) 1.67
Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants. Infect Control Hosp Epidemiol (1993) 1.66
Hepatitis induced by Noni juice from Morinda citrifolia: a rare cause of hepatotoxicity or the tip of the iceberg? Digestion (2006) 1.66
Malignant lymphoma, intermediate lymphocytic type: a clinicopathologic study of 42 cases. Cancer (1981) 1.65
Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood (1998) 1.65
Acute caecal volvulus. Br J Surg (1980) 1.63
Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Am J Med (1989) 1.62
Role of the herbicide atrazine in the development of non-Hodgkin's lymphoma. Scand J Work Environ Health (1993) 1.61
Drinking water nitrate and the risk of non-Hodgkin's lymphoma. Epidemiology (1996) 1.60
Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas. Lab Invest (1990) 1.60
The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res (1997) 1.59
High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. J Clin Oncol (1993) 1.58
Multiple lymphomatous polyposis of the gastrointestinal tract. Histopathology (1984) 1.58